Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sterilucent

1994 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Angel LATEST DEAL TYPE
$4.57M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of sterility assurance products. The company develops and markets vaporized (gas) hydrogen peroxide technology offering sterilization products.

Formerly Known As
Phygen
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Primary Office
  • 1400 Marshall Street North East
  • Minneapolis, MN 55413
  • United States

+1 (612) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sterilucent’s full profile, request a free trial.

Sterilucent Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Apr-2015 $4.57M 00.000 Completed Generating Revenue
1. Grant 01-Jan-2004 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Sterilucent Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0

Sterilucent Executive Team (2)

Name Title Board
Seat
Contact
Info
David Bell Founder, President & Chief Executive Officer
Stephen Loes Chief Operating Officer

Sterilucent Board Members (2)

Name Representing Role Since Contact
Info
Daniel Stenoien Sterilucent Board Member 000 0000
Shawn Featherston Sterilucent Board Member 000 0000